Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tale of two assays: Comparison of modern donor-derived cell-free DNA technologies

1 Apr 2024

Abstract excerpt

Little is known about the comparative differences between the Allosure (CareDx) and Prospera (Natera) donor derived cell-free DNA (dd-cfDNA) assays following heart transplantation. We retrospectively analyzed 248 consecutive samples that had both dd-cfDNA assays simultaneously performed. 26 biopsy specimens were available within 7 days from dd-cfDNA assays. Both dd-cfDNA assays were correctly suggestive of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Polyomavirus and related diseases
Share to Renal Transplantation Outcomes and Treatments
Share to Transplantation: Methods and Outcomes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40144271
DOI: 10.1016/j.jhlto.2024.100090

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tale of two assays: Comparison of modern donor-derived cell-free DNA technologiesPMID 40144271Read ↗

A novel donor-derived cell-free DNA assay for the detection of acute rejection in heart transplantationSemantic proximity Read ↗

A two-threshold algorithm using donor-derived cell-free DNA fraction and quantity to detect acute rejection after heart transplantationSemantic proximity Read ↗

Absolute quantification of donor-derived cell-free DNA following pediatric and adult heart transplantationSemantic proximity Read ↗

A modern heart transplant rejection surveillance protocol utilizing cell-free DNA: A single-center experienceSemantic proximity Read ↗

Graft-derived Cell-free DNA as a Noninvasive Biomarker of Cardiac Allograft Rejection: A Cohort Study on Clinical Validity and Confounding FactorsSemantic proximity Read ↗

Relationship Between Donor Derived Cell-Free DNA and Tissue-Based Rejection-Related Transcripts In Heart TransplantationSemantic proximity Read ↗

Donor-derived cell-free DNA is a valuable monitoring tool after single lung transplantation: Multicenter analysisSemantic proximity Read ↗

Cell-free DNA donor fraction analysis in pediatric and adult heart transplant patients by multiplexed allele-specific quantitative PCR: Validation of a rapid and highly sensitive clinical test for stratification of rejection probabilitySemantic proximity Read ↗

Why Cell-Free DNA Can Be a “Game Changer” for Lung Allograft Monitoring for Rejection and InfectionSemantic proximity Read ↗

Donor-derived cell-free DNA-based liquid biopsies to determine future kidney transplant rejectionSemantic proximity Read ↗

Validation of a Clinical-Grade Assay to Measure Donor-Derived Cell-Free DNA in Solid Organ Transplant Recipients.Semantic proximity Read ↗

Comparison of methods for donor-derived cell-free DNA quantification in plasma and urine from solid organ transplant recipientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.